240 related articles for article (PubMed ID: 19995858)
21. [Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases].
Fontes V; Machet L; Huttenberger B; Lorette G; Vaillant L
Ann Dermatol Venereol; 2002 Dec; 129(12):1365-9. PubMed ID: 12536172
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
[TBL] [Abstract][Full Text] [Related]
23. [Behcet's disease therapy review].
Vidaller Palacín A; Robert Olalla J; Sanuy Jiménez B; Rufi Rigau G; Folch Civit J; Charte González A
An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
[TBL] [Abstract][Full Text] [Related]
24. Atherosclerosis in Behçet's Syndrome.
Seyahi E; Ugurlu S; Cumali R; Balci H; Ozdemir O; Melikoglu M; Hatemi G; Fresko I; Hamuryudan V; Yurdakul S; Yazici H
Semin Arthritis Rheum; 2008 Aug; 38(1):1-12. PubMed ID: 18221989
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of aphthosis with thalidomide and with colchicine].
Genvo MF; Faure M; Thivolet J
Dermatologica; 1984; 168(4):182-8. PubMed ID: 6724071
[TBL] [Abstract][Full Text] [Related]
26. Development of de novo major involvement during follow-up in Behçet's syndrome.
Talarico R; Cantarini L; d'Ascanio A; Figus M; Favati B; Baldini C; Tani C; Neri R; Bombardieri S; Mosca M
Clin Rheumatol; 2016 Jan; 35(1):247-50. PubMed ID: 25750177
[TBL] [Abstract][Full Text] [Related]
27. Uveitis associated with pediatric behçet disease in the american midwest.
Kesen MR; Goldstein DA; Tessler HH
Am J Ophthalmol; 2008 Dec; 146(6):819-27.e2. PubMed ID: 18672222
[TBL] [Abstract][Full Text] [Related]
28. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
Melikoglu M; Fresko I; Mat C; Ozyazgan Y; Gogus F; Yurdakul S; Hamuryudan V; Yazici H
J Rheumatol; 2005 Jan; 32(1):98-105. PubMed ID: 15630733
[TBL] [Abstract][Full Text] [Related]
29. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
[TBL] [Abstract][Full Text] [Related]
30. [Behçet's disease].
Brand HS; van Beusichem FF; van Nieuw Amerongen A
Ned Tijdschr Tandheelkd; 2008 Jun; 115(6):340-5. PubMed ID: 18618988
[TBL] [Abstract][Full Text] [Related]
31. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.
Mishima S; Masuda K; Izawa Y; Mochizuki M; Namba K
Trans Am Ophthalmol Soc; 1979; 77():225-79. PubMed ID: 397657
[TBL] [Abstract][Full Text] [Related]
32. Comparison of patients with Behçet's disease in the 1980s and 1990s.
Yoshida A; Kawashima H; Motoyama Y; Shibui H; Kaburaki T; Shimizu K; Ando K; Hijikata K; Izawa Y; Hayashi K; Numaga J; Fujino Y; Masuda K; Araie M
Ophthalmology; 2004 Apr; 111(4):810-5. PubMed ID: 15051217
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Behçet's disease--an update.
Kaklamani VG; Kaklamanis PG
Semin Arthritis Rheum; 2001 Apr; 30(5):299-312. PubMed ID: 11303303
[TBL] [Abstract][Full Text] [Related]
34. Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome.
Kiliç H; Zeytin HE; Korkmaz C; Mat C; Gül A; Coşan F; Dinç A; Simşek I; Süt N; Yazici H
Rheumatology (Oxford); 2009 Nov; 48(11):1388-91. PubMed ID: 19717547
[TBL] [Abstract][Full Text] [Related]
35. A controlled trial of azathioprine in Behçet's syndrome.
Yazici H; Pazarli H; Barnes CG; Tüzün Y; Ozyazgan Y; Silman A; Serdaroğlu S; Oğuz V; Yurdakul S; Lovatt GE
N Engl J Med; 1990 Feb; 322(5):281-5. PubMed ID: 2404204
[TBL] [Abstract][Full Text] [Related]
36. [Behçet's disease].
Chiheb S; Chakib A; Lakhdar H
Ann Dermatol Venereol; 2003; 130(6-7):657-63. PubMed ID: 13679709
[No Abstract] [Full Text] [Related]
37. The association between the parenchymal neurological involvement and posterior uveitis in Behçet's syndrome.
Bitik B; Tufan A; Sahin K; Sucullu Karadag Y; Can Sandikci S; Mercan R; Ak F; Karaaslan Y; Ozturk MA; Goker B; Haznedaroglu S
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):82-85. PubMed ID: 27791948
[TBL] [Abstract][Full Text] [Related]
38. [Immunosuppressive therapy of Behcet's syndrome. Long term follow-up evaluation (author's transl)].
Bonnet M
J Fr Ophtalmol; 1981; 4(6-7):455-64. PubMed ID: 7299062
[TBL] [Abstract][Full Text] [Related]
39. [Childhood Behçet's disease: clinical and evolutive aspects. About 13 cases].
Laghmari M; Karim A; Allali F; Elmadani A; Ibrahimy W; Hajjaj Hassouni N; Chkili T; Elmalki Tazi A; Mohcine Z
J Fr Ophtalmol; 2002 Nov; 25(9):904-8. PubMed ID: 12515934
[TBL] [Abstract][Full Text] [Related]
40. [Behçet's disease. Apropos of 32 cases].
Bitar E; Ghayad E; Ghoussoub K; Sinno W; Chams H; Khoury A; Baloglou P; Kallab K; Halaby C; Chemaly R
Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):621-4. PubMed ID: 3616444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
